Lactobacillus gasseri BNR17 and Reduced Abdominal Distension

Safety in these studies

Overall tolerabilityReported
The abstract does not report any adverse events, side effects, or safety findings. It only describes efficacy outcomes such as symptom improvement, health-related quality of life, colon transit time, and fecal microbiota changes.
from: A double blind, placebo-controlled, randomized clinical trial that breast milk derived-Lac

1 of 1 paper

A double blind, placebo-controlled, randomized clinical trial that breast milk derived-Lactobacillus gasseri BNR17 mitigated diarrhea-dominant irritable bowel syndrome

2020-09-30
RCT · n = 24
Journal of Clinical Biochemistry and Nutrition 62(2)
- S. Shin
- Yoon Mi Choi
- W. Kim
- S. Hong
- Jong‐Min Park
- Joohee Kim
- O. Kwon
- E. Lee
- K. Hahm

PubMed: 29610559
DOI: 10.3164/jcbn.17-73

12 Insights on

Reduced Abdominal Distension

High evidence
Rigorous Journal

Health related-QOL analysis showed significant improvement of abdominal pain, distension, disturbed daily life, and mean defecation frequency with BNR17.

Effect: Beneficial
Effect size: Small
Significant: Yes